I'm LongbridgeAI, I can summarize articles.RBC Capital analyst Kendall Au maintained a Buy rating on Medtronic (MDT) with an $118 price target, noting the stock closed at $86.44. This follows TD Cowen's September 30 reiteration of a Buy rating with a $110 target. The broader analyst consensus for Medtronic is a Moderate Buy, with an average price target of $103.41, implying a 19.63% upside.
In a report released on October 1, Kendall Au from RBC Capital maintained a Buy rating on Medtronic, with a price target of $118.00. The company’s shares closed yesterday at $86.44.
Au covers the Healthcare sector, focusing on stocks such as Becton Dickinson, GE Healthcare Technologies Inc, and Boston Scientific. According to TipRanks, Au has an average return of -3.6% and a 22.22% success rate on recommended stocks.
Medtronic has an analyst consensus of Moderate Buy, with a price target consensus of $103.41, representing a 19.63% upside. In a report released on September 30, TD Cowen also reiterated a Buy rating on the stock with a $110.00 price target.